Skip to main content
. 2024 May 11;14:10823. doi: 10.1038/s41598-024-61697-w

Table 2.

Overall follow up.

Neg.
(n = 91)
Pos.
(n = 67)
p-value
Follow up, months 33.0 34.1 0.99
Rutgeerts-score, median 1.23 1.18 0.79
Severe endoscopic recurrence (i3-i4), n (%) 3/71 (4.2) 10/51 (19.6) 0.001
Clinical recurrence, n (%) 17 (18.5) 13 (19.4) 0.88
Surgical recurrence, n (%) 0 (0) 3 (4.5) 0.04
Immunosuppressive medication/biologicals, n (%) 57 (61.9) 48 (71.6) 0.24

Significant values are given in bold.